Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $374,253 - $716,780
28,076 Added 220.53%
40,807 $958,000
Q1 2023

May 10, 2023

BUY
$13.49 - $18.72 $171,741 - $238,324
12,731 New
12,731 $174,000
Q1 2022

May 13, 2022

SELL
$11.18 - $24.02 $112,918 - $242,602
-10,100 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $211,595 - $271,488
10,100 New
10,100 $239,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.07B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.